CAR T Cells Target TNF in Mouse Model of Rheumatoid Arthritis
A single infusion of engineered T cells degraded soluble TNF and produced durable disease control in mice
False
A single infusion of engineered T cells degraded soluble TNF and produced durable disease control in mice
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
September 30, 2026
10 min read
How direct T-cell reprogramming could simplify CAR-T manufacturing, expand patient access, and extend cellular immunotherapy to new indications
September 29, 2026
5 min read
Coordinated development and practical testing pathways can help ensure eligible patients are identified from the point of approval
September 28, 2026
3 min read
Phase I study will test whether a targeted lentiviral vector can generate BCMA-directed CAR T cells inside patients with multiple myeloma
September 28, 2026
2 min read
Renee Aguiar-Lucander argues that faster clinical trials and more pragmatic regulation are essential to bringing medicines to patients sooner
False
Affiliations:
Specialties:
Areas of Expertise: